What Are The Four Stages of Mesothelioma Cancer?

Brighan staging system, on the other hand, determines whether the Mesothelioma can be surgically removed or not and whether the lymph nodes are affected or not. In stage I Mesothelioma, the lymph nodes are not yet affected and the patient can still recover through surgery.

One rare form of cancer is called Mesothelioma, a malignant tumor in the mesothelial tissues of the lungs and the abdomen, arising from the inhalation of asbestos. Its rarity is one of the reasons why a lot of people are not aware of this kind of fatal disease. In fact, many people die of Mesothelioma undiagnosed.

Although there is now a growing awareness of the hazards of asbestos to health, still many have not heard of Mesothelioma and thus, have not understood its nature, cause, signs and treatment. Even some physicians find it hard to detect Mesothelioma because its symptoms are akin to other diseases like lung cancer and pneumonia. Furthermore, it takes decades for a patient who was exposed to asbestos to develop Mesothelioma ? fifty years, at most.

Being unaware of Mesothelioma poses higher risks since it deters diagnosis and treatment. A person undergoing treatment must know the different stages of the cancer or the extent of the disease. Chances of recovering from Mesothelioma and the kind of treatment depend on the stage of the illness. There are basically two staging systems used for Pleural Mesothelioma (lungs): TNM system and Brighan system. These staging systems are also used in other kinds of cancers; however, the first is commonly used. There is no established method in determining the stage of the Peritoneal Mesothelioma cancer (abdominal) so the TNM system is used.

There are three variables in the TNM system: tumor, lymph nodes and metastasis. In the earliest stage of Mesothelioma, stage I, the malignant Mesothelioma cells start to grow and multiply only one layer of the pleura. The pleura is the membrane that encloses the lungs and lines the wall of the chest cavity. However, there are some instances wherein the pericardium (membrane that covers the heart) and diaphragm cover are already affected. In this case, the cancer patient is still in stage I Mesothelioma.

In the second stage, the two layers of the pleura are already affected by Mesothelioma. Take note, however, that in this stage, only one side of the body is affected. Normally, the pleura produces only small amount of lubricating fluid that allows easy expanding and contracting of the lungs. The excess fluid is absorbed by the blood and the lymph vessels so there?s a balance between the amount of fluid produced and removed.

During the second stage Mesothelioma, fluid starts to build up between the membrane of the lungs and the membrane of the chest wall, resulting to pleural effusion. The increase in the volume of fluid produced causes shortness of breath and chest pain. Other Mesothelioma cancer patients experience dry and persistent cough. Diagnosis of the pleural effusion is achieved through a chest x-ray.

Stage III Mesothelioma means that the malignant cells have already spread to the chest wall, esophagus and the lymph nodes on one part of the chest. The patient may suffer severe pain near the parts affected. When not treated immediately or when the Mesothelioma patient doesn?t respond well to medication, the cancer may advance to the fourth stage.

The fourth stage Mesothelioma is formidable since at this stage the Mesothelioma cells have penetrated into the bloodstream and other organs in the body like the liver, the bones and the brain. The lymph nodes on the other side of the chest may also be affected by Mesothelioma in stage IV.

Brighan staging system, on the other hand, determines whether the Mesothelioma can be surgically removed or not and whether the lymph nodes are affected or not. In stage I Mesothelioma, the lymph nodes are not yet affected and the patient can still recover through surgery.

In stage II, surgery can still be executed but some lymph nodes have already been infiltrated by the cancer cells. In stage III, the heart and chest wall are already affected; thus, surgery is no longer advisable. The lymph nodes in this stage, however, may or may not be affected. In the final stage, stage IV Mesothelioma, cancer cells have already gone to the bloodstream and other parts of the body like the heart, brain, bone and liver. In most cases, a patient who has reached stage IV Mesothelioma only has four to twenty-four months to live.

Patients Of Gastric Cancer Therapy

Gastric cancer therapy is the most feasible option available for patients of gastric cancer to keep control on or eliminate malignant disorder in gastric region.
Therapy for gastric cancer can be of various forms and result into side-effects of various intensities depending upon certain basic aspects concerned with the victim. Undergoing proper and timely therapy helps to reduce chances of gastric cancer recurrence and also enables the victim to recover safely.

Gastric Cancer Therapy ? Meaning and Peculiarities
Therapy for gastric cancer is significant for varied reasons and gives immense advantage to victim in getting rid of infectious cells with least possible complications. Therapy can be used for both preventive and curative purposes and pattern may vary from person to person. Basic aspects considered before recommending a certain kind of therapy are age, personal medical background, gastric cancer stage a person is suffering from, gender, and type of cancerous growth.
Gastric or stomach cancer is prevalent in adults mostly older than 40 years and chances of infection are higher in males in comparison to females. Gastric cancer life expectancy is very less and it is very difficult to tackle the disorder in final stages. On an average, chances of survival are around 57-70% in the first stage which later drop to 33-45% in the second phase. Third stage rate of survival varies between 9-20% which later goes to mere 4% in the last or final phase. Majority of people suffering from gastric cancer die due to late or faulty gastric cancer diagnosis and late gastric cancer treatment.
Efficiency of treatment undergone in the past also plays an important role in deciding the chances of recurrence of malignant polyps. Those who have already gone through cure process for gastric or other kinds of cancerous growth need to be very careful while undergoing therapy once again as their body cells and tissues are weak and less resistant to infection. People suffering from serious non-cancerous disorders related to stomach or abdominal areas should be very particular about regular health checkups. Secondary form of gastric cancer is more difficult to cure in comparison to primary one.
Main Gastric Cancer Therapies
Surgery is a form of therapy useful to treat early stages of the gastric cancer. Gastrectomy is the most basic and standard surgical pattern to remove wither only the infected part of stomach (subtotal gastrectomy) or full stomach along with a part of esophagus, spleen, and small intestine (total gastrectomy). Other forms of surgery are endoluminal stent placement (stent is inserted to make bypass near blocked passages), gastrojejunostomy (removing infected portion of stomach that may be blocking opening of small intestine), and endoluminal laser therapy.
Other forms of therapies include cryosurgery (killing infected cells and tumors by exposing them to liquid nitrogen), chemoradiation (combination of chemotherapy and radiotherapy), chemotherapy (exposing tumors to chemicals or recommending medically prescribed medicines to keep tumor-growth under control), and radiotherapy (killing tumors or burning the infected area by passage of strong radiations). Targeted therapy pattern can also be used to treat only the infected area without causing harm to nearby healthy tissues. Immunotherapy is a form of both curative and preventive way to deal with gastric cancer and needs to be supported by healthy diet and active lifestyle.
Gastric cancer therapy can be effective if habits like smoking, alcohol drinking, and chewing tobacco are avoided. One should also focus on eating nutritious diet that is easy to digest and puts less strain on the overall digestive system. Infections or inflammations in stomach or abdomen areas should be taken care of well in time and medication should be undergone only under expert medical supervision.

A Cancer Patient Instead Of A Swine Feeder?

In the fifteenth chapter of the book of Luke there is to be found one of the most poignantly beautiful stories of redemption and restoration in all of literature. Surely all of you are familiar with this story of a younger brother who persuades his father to give him his inheritance as though the father had died. As the story goes, he then went to a foreign land and wasted his funds in riotous living. His money ran out just as a famine gripped the land he had chosen and he was reduced to the role of a swine feeder in the filthiest of conditions. He then decided to go home and throw himself on his father's mercy and was, happily, extremely well received. This brings us to the central character of the story who was not the prodigal, but rather the older brother who was angered by the whole proceedings. He made it known that his first concern was financial and was based on his brother's handling of his money and the fact that he had come back for more. The story does not tell the ultimate outcome. We do not know if the older brother was ever able to reconcile with his father with the humility that the younger, repentant brother displayed.
Now let us fast forward to today and a currently developing story that bears a strong resemblance to the bible story in view of attitudes found within the community. There is a man in Granbury, Texas by the name of Rex Covert who has just completed a very real journey to hell and back. This started for him with the discovery that he had colo-rectal cancer that had already metastasized to distant organs. Add to the complications that Rex is a 90 year old man and you have what developed as a rather sordid picture of our times. I can only surmise that there must have been a sense of both jubilation and haste when the hospital folks saw a 90 year old cash cow coming through the door. They appear to have thrown every billable process, medication and procedure at him that was available at their facility with the result that by late summer he was bedfast and near death with hospice already on the scene. I had known Rex for many years and when he called me for help, I went immediately.
He would not receive me at his bedside and insisted that he be propped up in a chair in his living room where we engaged in a rather lengthy conversation about my experience in the field of mind/body medicine. Our conversation went very deep into Rex's personal life, at his leading, not mine. Before it was over, he broke down and cried his heart out as I held him in my arms. These were not tears of sorrow or self pity but rather, tears of joy at being released from some burdens that had troubled him for decades. He declared that he felt better and walked unassisted back to his bed. I had just received a package containing 5 proof copies of the new Alpha Wave modulated CD of guided imagery for cancer patients and I left one with him which he assured me he would faithfully use. This pretty much ended my involvement with Rex as the rest was left up to him and this is his story, not mine. Within about 3 months, he had regained his lost weight, resumed his walking exercise program and tests could find no cancer. What a remarkable, unbelievable story this turned out to be. Rex's story is, in fact, a story within a story as four other discs were sent to patients who all had positive responses that ranged from stable disease to full remission. Rex's story was by far the most dramatic. I thought it worthwhile to conduct a small "attitude survey" among several people from select walks of life. It is sometimes tough to tell these stories as people generally are not interested in hearing them. I was curious to see if a common thread of response would run through all the interviews and, sure enough, it did. Here are the results of my little survey:
1) A doctor thought this was "interesting" but since it was not done under proper scientific conditions could not be viewed as having much value. Again the use of the word "anecdotal" - this has become a convenient word as it has become an accepted vehicle for dismissing that which we really don't understand. The NCI has never come up with an answer to the question of "What if the anecdotal evidence is true?".
2) A neighbor of deep religious conviction who simply worried about me and cautioned that I might be in danger of putting myself up as equal to God and that I should be alert to any danger of my immortal soul. No interest in the details of what happened.
3) A person involved in cancer research who was considerably irritated that a layman such as I really had no business playing in the professionals yard. Again no interest in the details or how they might possibly and favorably impact his own work.
4) A cancer patient who felt that I was just not "scientific" enough to be doing this sort of work and felt that her doctor would be offended if she got off into something like this. (she just LOVES her doctor). She was not interested in finding out more of what Rex had done to bring about this miracle. I think this was the most interesting response of all considering that it came from someone who had never had an original thought in her life, scientific or otherwise. I used to argue this point with the doctors on the KCA board. I always mentioned that in my own career in plasma physics and theoretical fluid mechanics I racked up a score or 27 patents in 9 different countries while asking how many original scientific discoveries any of them had made - of course the answer was no. It comes as no surprise that my term on the board was not renewed.
5) A young minister whose first thought was to counsel me on the concern that I might be interfering with God's work. He was not forthcoming as to the scriptural basis for this concern. He never once asked for details.
There is an amazing consistency of disinterest running through the above that bears a striking similarity to the parable of the Prodigal Son, who is, himself, really not the central character of Jesus' story. No. this story was about the older brother who just happened to be the only one of all the characters who was not happy with the outcome. He saw only the financial aspects. None of the people above were joyful at the report that, as the father in the parable put it, "The dead is alive and the lost is found". I suspect that there are with us today, many forward looking oncologists who would find Rex's case of significant interest. I hope so as meaningful discourse on this case, in itself, would be cause for celebration as it could amount to a positive indication that the oncology worm is finally turning from a locked in mindset that is solely pharmaceutical. We are not threatening their treatment protocol -WE ARE TRYING OUR BEST TO ENHANCE IT!
The true essence of all science is expressed in three words "Observing and Inferring". The world is free of smallpox today because a man named Jenner, in the 1700's observed that milkmaids in his community did not seem to get smallpox. Inferring correctly from that observation he proceeded on a healing journey, no doubt over the ridicule of many of his peers in the medical community of his day and smallpox became history. Scientific observation is not limited to any organization or political system.
Let us take this wonderful outcome of tests simply for what it is - a Christmas miracle in the form of answered prayer. Rex, keep on doing what you are doing as you have made at least some of us very, very happy!!
Gerald White, P.E.
Back in 1993 Gerald White survived a 20 pound kidney tumor that subsequently went metastatic to distant organs. After all medical treatments had failed and the dreadful "only three more months" death sentence had been delivered. He worked out a self- directed program of guided imagery that induced a remission in three months. He has served a three year term as a Director of the National Kidney Cancer Association. Through his webpage he maintains an active world wide mentoring program that has yielded many similar remissions of cases thought to be hopeless. His book has been translated into Chinese and Hungarian. A credible Scientist, in his career before cancer, he achieved some 20 technology patents in 9 countries.

Dangers Barbecued Food and Tips to Prevent Cancer

Recent studies have found that smoked or barbecued food may be more hazardous they are thought of. However, there are some tips you can follow to enjoy your barbecue and lower its health risks as much as possible.
The root cause of health risks associated with barbecued food is the meat. Recent research has found that poultry, red meat, lamb, pork, and fish can emit two carcinogenic substances when they are barbecued.
The first cancerous substance is heterocyclic amine, which are deemed reasonable carcinogenic by the National Institute of Health. Heterocyclic amines or HCAs are produced when the meat is overcooked or char-grilled over high temperatures. Studies with rodents have shown that those rodents with HCA contracted diseases cancer in multiple organs later, including the colon, prostate, and breast. The effect on humans is still being researched.
The second cancerous substance is polycyclic aromatic hydrocarbon, abbreviated as PAH. PAHs are carried onto the food through the smoke that forms when fat from the meat drips onto the hot charcoal. PAH is directly formed on the food when it is char-grilled.
Both of these cancerous substances can be avoided if you follow a healthy barbecuing recipe. The following tips will help you prepare a healthy barbecue meal:
Cook at the right temperature
Overcooked or precooked food should be avoided, and you should keep the temperature of the grille just right. You should also avoid any step in the preparation process that might increase the cooking time of the food. A good practice to follow is to flip the meat frequently and to keep the grille at a low temperature. You can also buy thinner slices of meat so that they cook at lower temperatures and in a shorter time. Before you begin the barbecue, you should try to measure the temperature and see that it matches the USDA-recommended minimum temperatures mentioned below (all temperatures in degrees Fahrenheit):
· Chicken breast and whole poultry: 165
· Pork and ground beef: 160
· Steaks, roasts, and fish: 145
Choose lean meat
In order to prevent PAH, you should trim as much fat from the meat as you can before cooking it. This will be much easier if you choose lean meat cuts. While cooking the meat, flip it frequently to avoid the fat from dripping down and avoid stabbing the meat.
Marinate longer
Recent studies have found that some meat marinating ingredients, like vinegar, may be helpful in preventing the two cancerous substances from forming. One study found that beef marinated with teriyaki sauce had 67 percent less HCA than the steak without the marinade.

The Systematic Identification Researchers Genetic Markers Of Drug Sensitivity In Cancer Cells

In the largest study of its kind, researchers have profiled genetic changes in cancer with drug sensitivity in order to develop a personalised approach to cancer treatments. The study is published in Nature on Thursday 29 March 2012.

The team uncovered hundreds of associations between mutations in cancer genes and sensitivity to anticancer drugs. One of the key responses the team found was that cells from a childhood bone cancer, Ewing's sarcoma, respond to a drug that is currently used in the treatment of breast and ovarian cancers. The lowered toxicity of this treatment may mean it is a safer alternative therapy for children and young adults with this aggressive cancer.
There is an intimate relationship between the way a drug works and the genetic changes present in cancers. This study found that sensitivity to most anti-cancer drugs is influenced by mutations in cancer genes and establishes the utility of using large-scale studies to identify these associations and build them into improved patient treatment.
"Our key focus is to find how to use cancer therapeutics in the most effective way by correctly targeting patients that are most likely to respond to a specific therapy," explains Dr Mathew Garnett, first author from the Wellcome Trust Sanger Institute. "We studied how genetic changes in a panel of >600 cancer cell lines effects responses to 130 anti-cancer drugs, making it the largest study of this type to date."
The team identified biological markers of drug sensitivity to a broad range of cancer drugs. Most of the cancer genes analysed, including those that are not known directs targets of the drugs tested, were associated with either sensitivity or resistance to at least one of the drugs analysed.
"Our research has taken us down unknown paths to find associations that are completely novel," says Dr Cyril Benes, senior author from Massachusetts General Hospital Cancer Centre. "We have identified hundreds of associations, many of which we still don't fully understand. We identified a novel indication for the use of PARP inhibitors, anti-cancer drugs currently used to treat breast and ovarian cancers, for the treatment of Ewing's sarcoma."
Ewing's sarcoma is a cancer of children and young adults with a 15% five-year survival rate in patients where the cancer has spread or they have relapsed after chemotherapy. The use of PARP inhibitors could represent a new treatment option for Ewing's sarcoma patients and these compounds will now be tested in clinical trials to assess their therapeutic benefit.
"Advances in next-generation sequencing technologies are already being translated into the large-scale detection of cancer gene mutations in the clinic," says Dr Ultan McDermott, senior author from the Wellcome Trust Sanger Institute. "There is a compelling need to identify, in a systematic fashion, whether observed mutations affect the likelihood of a patient's response to a given drug treatment. We have therefore developed a unique online open-access resource for the research and medical community that can be used to optimize the clinical application of cancer drugs as well as the design of clinical trials of investigational compounds being developed as treatments."
The team hopes their open-access database will be an important resource for the cancer research community and which will ultimately lead to improved treatments for patients. This research program is a unique Wellcome Trust funded 5-year collaboration between The Cancer Genome Project at the Wellcome Trust Sanger Institute and the Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center.
"Our work is helping to move cancer therapeutics away from the conventional tissue-based treatment to a more molecular-based treatment," says Professor Daniel Haber, senior author from Massachusetts General Hospital Cancer Centre. "The next steps for this collaborative project are to evaluate some of the key findings using tumour samples and test new candidate therapeutic strategies in clinical trials so we can hopefully improve the way we treat cancer patients. We are continuing our screening effort, in particular using drug combinations to discover innovative and better therapeutic options."

Cancer Diasease

As cancer cells use the body.

Lung Cancer